Search Results - "Kinkel, R"

Refine Results
  1. 1

    In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI by MAINERO, C, BENNER, T, RADDING, A, VAN DER KOUWE, A, JENSEN, R, ROSEN, B. R, KINKEL, R. P

    Published in Neurology (22-09-2009)
    “…We used ultra-high field MRI to visualize cortical lesion types described by neuropathology in 16 patients with multiple sclerosis (MS) compared with 8…”
    Get full text
    Journal Article
  2. 2

    Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis by Jacobs, Lawrence D, Beck, Roy W, Simon, Jack H, Kinkel, R. Phillip, Brownscheidle, Carol M, Murray, Thomas J, Simonian, Nancy A, Slasor, Peter J, Sandrock, Alfred W

    Published in The New England journal of medicine (28-09-2000)
    “…Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system that most commonly affects women, with an onset typically…”
    Get full text
    Journal Article
  3. 3

    Multiple sclerosis susceptibility genes: associations with relapse severity and recovery by Mowry, Ellen M, Carey, Robert F, Blasco, Maria R, Pelletier, Jean, Duquette, Pierre, Villoslada, Pablo, Malikova, Irina, Roger, Elaine, Kinkel, R Phillip, McDonald, Jamie, Bacchetti, Peter, Waubant, Emmanuelle

    Published in PloS one (09-10-2013)
    “…Patients with early multiple sclerosis (MS) have stereotyped attack severity and recovery. We sought to determine if polymorphisms in MS susceptibility genes…”
    Get full text
    Journal Article
  4. 4

    Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH-T2 by Nielsen, A. Scott, Kinkel, R. Philip, Tinelli, Emanuele, Benner, Thomas, Cohen-Adad, Julien, Mainero, Caterina

    Published in Journal of magnetic resonance imaging (01-03-2012)
    “…Purpose: To evaluate the inter‐rater agreement of cortical lesion detection using 7 Tesla (T) FLASH‐T2* and 3T DIR sequences. Materials and Methods: Twenty‐six…”
    Get full text
    Journal Article
  5. 5

    Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab by Chen, Yiping, Bord, Evelyn, Tompkins, Troy, Miller, Janice, Tan, Chen S, Kinkel, R. Philip, Stein, Marion C, Viscidi, Raphael P, Ngo, Long H, Koralnik, Igor J

    Published in The New England journal of medicine (10-09-2009)
    “…Progressive multifocal leukoencephalopathy (PML) is a rare complication of natalizumab treatment and is caused by the JC virus. In this study of 19 patients…”
    Get full text
    Journal Article
  6. 6

    Internet portal use in an academic multiple sclerosis center by Nielsen, A Scott, Halamka, John D, Kinkel, R Philip

    “…To evaluate the use of a secure internet portal in an academic Multiple Sclerosis (MS) Center. Retrospective case-control chart review of 240 patients during…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Axonal loss in normal-appearing white matter in a patient with acute MS by BJARTMAR, C, KINKEL, R. P, KIDD, G, RUDICK, R. A, TRAPP, B. D

    Published in Neurology (09-10-2001)
    “…Brain imaging studies detect abnormalities in normal-appearing white matter in patients with MS. To investigate the histopathologic basis for these changes in…”
    Get full text
    Journal Article
  10. 10

    Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria by O’Connor, P, Kinkel, RP, Kremenchutzky, M

    Published in Multiple sclerosis (01-06-2009)
    “…Approximately 85% of multiple sclerosis (MS) cases begin as clinically isolated syndromes (CIS). Results from the Controlled High-Risk Subjects Avonex®…”
    Get full text
    Journal Article
  11. 11

    JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis by Chalkias, Spyridon, Dang, Xin, Bord, Evelyn, Stein, Marion C., Kinkel, R. Philip, Sloane, Jacob A., Donnelly, Maureen, Ionete, Carolina, Houtchens, Maria K., Buckle, Guy J., Batson, Stephanie, Koralnik, Igor J.

    Published in Annals of neurology (01-06-2014)
    “…Objective To determine the prevalence of JC virus (JCV) reactivation and JCV‐specific cellular immune response during prolonged natalizumab treatment for…”
    Get full text
    Journal Article
  12. 12

    Association of multiple sclerosis susceptibility variants and early attack location in the CNS by Mowry, Ellen M, Carey, Robert F, Blasco, Maria R, Pelletier, Jean, Duquette, Pierre, Villoslada, Pablo, Malikova, Irina, Roger, Elaine, Kinkel, R Phillip, McDonald, Jamie, Bacchetti, Peter, Waubant, Emmanuelle

    Published in PloS one (10-10-2013)
    “…The anatomic location of subsequent relapses in early multiple sclerosis (MS) appears to be predicted by the first attack location. We sought to determine if…”
    Get full text
    Journal Article
  13. 13

    In vivo evidence of disseminated subpial T2 signal changes in multiple sclerosis at 7 T: a surface-based analysis by Cohen-Adad, J, Benner, T, Greve, D, Kinkel, R P, Radding, A, Fischl, B, Rosen, B R, Mainero, C

    Published in NeuroImage (Orlando, Fla.) (01-07-2011)
    “…Cortical subpial demyelination is frequent in multiple sclerosis (MS) and is closely associated with disease progression and poor neurological outcome…”
    Get full text
    Journal Article
  14. 14

    Ten-year follow-up of the ‘minimal MRI lesion’ subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial by Simon, JH, Kinkel, RP, Kollman, C, O’Connor, P, Fisher, E, You, X, Hyde, R

    Published in Multiple sclerosis (01-04-2015)
    “…Background: Patients with clinically isolated syndrome (CIS) and characteristic magnetic resonance imaging (MRI) lesions are at high risk for multiple…”
    Get full text
    Journal Article
  15. 15

    Brain MRI lesions and atrophy are related to depression in multiple sclerosis by Bakshi, Rohit, Czarnecki, Donna, Shaikh, Zubair A, Priore, Roger L, Janardhan, Vallabh, Kaliszky, Zoltan, Kinkel, Peter R

    Published in Neuroreport (27-04-2000)
    “…It is unclear whether brain MRI lesions are associated with depression in multiple sclerosis (MS). Neurological dysfunction in depressed (n = 19) and…”
    Get full text
    Journal Article
  16. 16

    Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy by Miravalle, Augusto, Jensen, Rikke, Kinkel, R Philip

    Published in Archives of neurology (Chicago) (01-02-2011)
    “…To assess clinical consequences of temporary natalizumab dosage suspension. Prospective cohort study. Multiple sclerosis (MS) center at an academic medical…”
    Get more information
    Journal Article
  17. 17

    Disease-related determinants of quality of life 10 years after clinically isolated syndrome by Kinkel, R Philip, Laforet, Genevieve, You, Xiaojun

    Published in International journal of MS care (01-01-2015)
    “…The main clinical determinants of quality of life (QOL) 5 years after clinically isolated syndrome (CIS) are Expanded Disability Status Scale (EDSS) score and…”
    Get full text
    Journal Article
  18. 18

    High‐Resolution Fluorodeoxyglucose Positron Emission Tomography Shows Both Global and Regional Cerebral Hypometabolism in Multiple Sclerosis by Bakshi, Rohit, Miletich, Robert S., Kinkel, Peter R., Emmet, Marja L., Kinkel, William R.

    Published in Journal of neuroimaging (01-10-1998)
    “…The authors study brain regional glucose metabolism prospectively in multiple sclerosis (MS) using high‐resolution 2‐[18‐F]fluoro‐2‐deoxy‐D‐glucose positron…”
    Get full text
    Journal Article
  19. 19

    Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis by Tuohy, V K, Yu, M, Yin, L, Kawczak, J A, Kinkel, R P

    Published in The Journal of experimental medicine (05-04-1999)
    “…Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for multiple sclerosis (MS). EAE is typically initiated by CD4(+) T helper cell…”
    Get full text
    Journal Article
  20. 20